Dimera Incorporated is a small west coast company dedicated to discovering novel medical concepts to address important medical needs (i.e., the leading cause of death and dysfunction, which is cardiovascular disease) for women and men. You are invited to visit often, as you will find frequent updates to this website that highlight research progress on cardiovascular (CV) disease--the number 1 killer.
Dimera Incorporated has developed the 1st heart drug for women. Dimera approaches the different underlying cause (microvascular ischemia) in women by systemically discovering the causes--rather than just the symptoms. This more arduous path has important virtues, allowing discovery of the molecular pathway causing the problem, while simultaneously minimizing unwanted side-effects.
The menu on the left side of each Dimera webpage provides several aspects of new insights into angina pectoris (chest symptoms caused by heart disease).
In the July 2008 issue of Nature Clinical Practice Cardiovascular Medicine, Dimera differentiates the beneficial actions on the heart of progesterone from the adverse actions of prevalent prescribed (synthetic) progestins.
© 1997-2009 Dimera Incorporated